DE2613345C3 - Verfahren zur Herstellung von 2-(2-Hydroxy-2-propyl)-l-methyl-5-nitroimidazol - Google Patents

Verfahren zur Herstellung von 2-(2-Hydroxy-2-propyl)-l-methyl-5-nitroimidazol

Info

Publication number
DE2613345C3
DE2613345C3 DE2613345A DE2613345A DE2613345C3 DE 2613345 C3 DE2613345 C3 DE 2613345C3 DE 2613345 A DE2613345 A DE 2613345A DE 2613345 A DE2613345 A DE 2613345A DE 2613345 C3 DE2613345 C3 DE 2613345C3
Authority
DE
Germany
Prior art keywords
nitroimidazole
methyl
hydroxy
propyl
added
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2613345A
Other languages
German (de)
English (en)
Other versions
DE2613345B2 (de
DE2613345A1 (de
Inventor
Werner Dr. Bottmingen Hofheinz (Schweiz)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE2613345A1 publication Critical patent/DE2613345A1/de
Publication of DE2613345B2 publication Critical patent/DE2613345B2/de
Application granted granted Critical
Publication of DE2613345C3 publication Critical patent/DE2613345C3/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91—Nitro radicals
    • C07D233/92—Nitro radicals attached in position 4 or 5
    • C07D233/94—Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to other ring members

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE2613345A 1975-04-04 1976-03-29 Verfahren zur Herstellung von 2-(2-Hydroxy-2-propyl)-l-methyl-5-nitroimidazol Expired DE2613345C3 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH429175 1975-04-04
CH82676 1976-01-23

Publications (3)

Publication Number Publication Date
DE2613345A1 DE2613345A1 (de) 1976-10-07
DE2613345B2 DE2613345B2 (de) 1978-05-18
DE2613345C3 true DE2613345C3 (de) 1979-01-04

Family

ID=25685810

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2613345A Expired DE2613345C3 (de) 1975-04-04 1976-03-29 Verfahren zur Herstellung von 2-(2-Hydroxy-2-propyl)-l-methyl-5-nitroimidazol

Country Status (7)

Country Link
US (1) US4042597A (enExample)
JP (1) JPS51127074A (enExample)
AR (1) AR207279A1 (enExample)
BR (1) BR7602031A (enExample)
DE (1) DE2613345C3 (enExample)
ES (1) ES446674A1 (enExample)
FR (1) FR2306204A1 (enExample)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2447414A (en) * 1946-01-18 1948-08-17 Monsanto Chemicals Oxidation of isopropylbiphenyl
US3402205A (en) * 1961-09-13 1968-09-17 Hercules Inc Polyperoxides
DE1233839B (de) * 1965-09-08 1967-02-09 Bayer Ag Verfahren zur Herstellung von alpha,alpha,alpha',alpha'-Tetra-methyl-xylylen-dicarbon
US3567786A (en) * 1967-07-31 1971-03-02 Allied Chem Oxidation of tertiary alkyl-substituted aryl compound to tertiary alcohol
US3794642A (en) * 1973-01-15 1974-02-26 Lilly Co Eli Oxidation of substituted methanes to the corresponding substituted methanols

Also Published As

Publication number Publication date
BR7602031A (pt) 1976-10-05
US4042597A (en) 1977-08-16
ES446674A1 (es) 1977-10-16
FR2306204B1 (enExample) 1978-11-17
DE2613345B2 (de) 1978-05-18
DE2613345A1 (de) 1976-10-07
FR2306204A1 (fr) 1976-10-29
JPS51127074A (en) 1976-11-05
AR207279A1 (es) 1976-09-22

Similar Documents

Publication Publication Date Title
DE2527937A1 (de) Benzcycloamidderivate und verfahren zu ihrer herstellung sowie pharmazeutische mittel, worin sie enthalten sind
DE2222491C3 (de) Steroid-21-salpetersäureester der Pregnanreihe, solche enthaltende Arzneimittel und Verfahren zur Herstellung derselben
DE1518333C3 (de) N,N-substituierte 4-Methylsulfonyl-2,6-dinitroaniline, Verfahren zu ihrer Herstellung und deren Verwendung
DE3103372A1 (de) Neue indanyl-derivate, ihre herstellung und verwendung
DE2613345C3 (de) Verfahren zur Herstellung von 2-(2-Hydroxy-2-propyl)-l-methyl-5-nitroimidazol
DE1468311C3 (de) 6-Chlor-4,6-pregnadien-3beta-17 alpha-diol-20-on-17-acetat-3methyläther sowie Verfahren zu dessen Herstellung und diesen enthaltende pharmazeutische Zubereitungen
CH642615A5 (de) Diphenylaether und verfahren zu deren herstellung.
DE3116913A1 (de) Verfahren zur herstellung von resorcinderivaten sowie verwendung bestimmter resorcinderivate als riechstoffe
DE69003616T2 (de) Diarylcycloalkanether.
DE3109281C2 (de) Verfahren zur Herstellung von 7α-Acylthio-4-en-3-oxosteroiden
DD160418A1 (de) Verfahren zur herstellung von 17alpha-substituierten gona-4,9-dienen
DE1955006A1 (de) Alkanolaminderivate und Verfahren zu deren Herstellung
DE2016467C3 (de) Verfahren zur Herstellung von 1 -Hydroxy-6-nieder-alkoxy-phenazin-5,10-dioxiden
DE2917178C2 (enExample)
DE2039466C3 (de) Dioxocyclohexancaibonsäureanilide und -thioanilide und Verfahren zu ihrer Herstellung
EP0029117B1 (de) 10-Bromsandwicin und 10-Bromisosandwicin sowie deren Säureadditionssalze mit pharmakoloyisch annehmbaren Säuren, Verfahren zu deren Herstellung und deren Verwendung
DE1768161C (de) Äther des 1 a, 2 a-Methylen-19-nor-testosterons und seiner 18- Alkylhomologen, Verfahren zu ihrer Herstellung, diese enthaltende Arzneimittel sowie entsprechende S a-östran-Zwischenprodukte
DE2757459A1 (de) Benzoylphenoxyessigsaeure-derivate
DE101778C (enExample)
DE1593407C3 (de) 17beta-Hydroxy-2-oxaöstra-4,9(10)dien-3-on sowie Verfahren zur Herstellung dieser Verbindung
EP0614890A2 (de) Gegebenenfalls 2-substituierte 5-Chlorimidazole
DE1793578C3 (de) Thionosalicylsäureanilide und Verfahren zu ihrer Herstellung. Ausscheidung aus: 1568522
AT381938B (de) Verfahren zur herstellung von neuen spirobenzofuranonverbindungen
AT246732B (de) Verfahren zur Herstellung von neuen Camphersulfonaten
DE2366559C2 (de) 1-substituierte 3-Aminopyrazolone-(5) sowie deren Verwendung

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
EHJ Ceased/non-payment of the annual fee